Opening book details…
About this Medicine article
P4‐663: INITIATION OF THE PHASE 2/3 GAIN TRIAL OF COR388, A NOVEL BACTERIAL VIRULENCE FACTOR INHIBITOR FOR THE TREATMENT OF ALZHEIMER'S DISEASE (AD) BASED ON PHASE I A/B SAFETY, PK, BIOMARKER AND EFFICACY DATA by Detke, Mike; Lynch, Casey; Holsinger, Leslie; Kapur, Shirin; Hennings, Dave; Raha, Debasish; Ermini, Florian; Haditsch, Ursula; Ryder, Mark; Goodman, Ira J.; Thein, Stephen G.; Dominy, Steve is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Detke, Mike; Lynch, Casey; Holsinger, Leslie; Kapur, Shirin; Hennings, Dave; Raha, Debasish; Ermini, Florian; Haditsch, Ursula; Ryder, Mark; Goodman, Ira J.; Thein, Stephen G.; Dominy, Steve
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV; Wiley; Research Square (ISSN 1552-5260)
- Published
- 2019
- Field
- Medicine (Health Sciences)